• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 24
  • 14
  • 4
  • 2
  • 1
  • 1
  • Tagged with
  • 51
  • 47
  • 34
  • 24
  • 15
  • 15
  • 9
  • 8
  • 8
  • 8
  • 7
  • 7
  • 7
  • 7
  • 7
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
21

Ras-dependent and Ras-independent effects of PI3K in Drosophila motor neurons

January 2012 (has links)
The lipid kinase PI3K plays key roles in cellular responses to activation of receptor tyrosine kinases or G protein coupled receptors such as the metabotropic glutamate receptor (mGluR). Activation of the PI3K catalytic subunit p110 occurs when the PI3K regulatory subunit p85 binds to phosphotyrosine residues present in upstream activating proteins. In addition, Ras is uniquely capable of activating PI3K in a p85-independent manner by binding to p110 at amino acids distinct from those recognized by p85. Because Ras, like p85, is activated by phosphotyrosines in upstream activators, it can be difficult to determine if particular PI3K-dependent processes require p85 or Ras. Here we ask if PI3K requires Ras activity for either of two different PI3K-regulated processes within Drosophila larval motor neurons. To address this question, we determined the effects on each process of transgenes and chromosomal mutations that decrease Ras activity, or mutations that eliminate the ability of PI3K to respond to activated Ras. We found that PI3K requires Ras activity to decrease motor neuron excitability, an effect mediated by ligand activation of the single Drosophila mGluR DmGIuRA. In contrast, the ability of PI3K to increase synaptic bouton number is Ras independent. These results suggest that distinct regulatory mechanisms underlie the effects of PI3K on distinct phenotypic outputs. We additionally found that the glutamate-activation of DmGIuRA initiates ERK signaling; however the signaling intermediates linking DmGIuRA to this kinase cascade are unknown.
22

Synthesis of original fluorinated cyclopropylcarboxylates

Ivashkin, Pavel 22 November 2013 (has links) (PDF)
Organofluorine compounds constitute a large part of all the drugs, crop protection agents and advanced materials produced nowadays. Therefore, there is a great interest in developing the new methods of synthesis of organofluorine compounds. In this thesis we report a novel method of synthesis of monofluorinated cyclopropanes based on the Michael-initiating ring closure (MIRC) reaction. Our method allows obtaining polysubstituted monofluorinated cyclopropanes from ethyl dibromofluoroacetate and various Michael acceptors. We have also implemented the asymetric version of cyclopropanation using a novel oxazolodinone-derived chiral fluorinated reagent. In the final part of this thesis we report the synthesis of a fluorinated analog of L-FAP4, a potent agonist of group II metabotropic glutamate receptors (mGluR II). Incorporation of a fluorine atom is expected to increase the biological activity and bioavailabiblity of this compound.
23

Synaptic plasticity in the lateral habenula controls neuronal output : implications in physiology and drug addiction / La plasticité synaptique dans l'habénula latérale contrôle la décharge neuronale : implications en physiologie et l'addiction aux drogues

Valentinova, Kristina 16 September 2016 (has links)
La survie des individus dépend de leur capacité d’anticiper la survenue d’une récompense ou d’un danger leur permettant ainsi de s’adapter à leur environnement. De considérables efforts ont été réalisés pour identifier les mécanismes cellulaires et synaptiques ayant lieu au niveau du circuit de la récompense afin d’avoir une meilleure compréhension des processus sous tendant des états motivationnels physiologiques et pathologiques tels que l’addiction et la dépression. Pour autant, ce n’est que récemment qu’on commence à comprendre les circuits capables de contrôler les systèmes monoaminergiques mésencéphaliques et leurs contributions aux comportements motivés. Dans les dernières décennies l’habénula latérale (LHb) a émergé comme un acteur majeur capable d’encoder des stimuli de valeur motivationnelle et de contrôler les systèmes monoaminergiques. La connectivité de cette structure épithalamique joue un rôle clé dans différents aspects des comportements motivationnels, comme l’approche et la fuite. Des avancées récentes ont aussi démontré que des altérations de la fonction de la LHb entrainent des états émotionnels négatifs caractéristiques de la dépression et l’addiction. Ces observations suggèrent que la LHb pourrait s’avérer une cible importante pour le traitement de ces pathologies. Au cours de mon travail de thèse, j’ai d’abord cherché à comprendre comment moduler la transmission synaptique au niveau de la LHb pouvait contrôler son activité. Pour répondre à cette question, je me suis focalisée sur le rôle des récepteurs métabotropiques au glutamate (mGluRs). Dans une seconde étude, j’ai examiné les mécanismes par lesquels les drogues d’abus modifient la transmission synaptique des neurones de la LHb. Ces modifications se produisent spécifiquement dans les neurones LHb se projetant vers le noyau tegmental rostral (RMT) et sont nécessaires pour l’émergence des états dépressifs. Dans un premier temps, nous avons démontré qu’au niveau de la LHb les mGluRs de type I sont capables d’induire une dépression à long terme de la transmission synaptique excitatrice (eLTD) et inhibitrice (iLTD). Ces deux formes de plasticité dépendent de la signalisation PKC, mais requièrent des mécanismes d’expression différents. Tandis que eLTD réduit la probabilité de libération du glutamate via l’activation de récepteurs présynaptiques aux endocannabinoides (CB1), iLTD s’exprime par la réduction de la fonction des récepteurs GABAA postsynaptiques contenant la sous-unité β2. De plus, eLTD and iLTD exercent un contrôle bidirectionnel sur la décharge des neurones de la LHb. Dans un second temps, nous avons mis en évidence qu’une exposition chronique à la cocaïne produit une augmentation persistante de la transmission excitatrice au niveau des neurones de la LHb ciblant le RMTg. Cette forme de potentialisation synaptique nécessite l’insertion membranaire de récepteurs contenant la sous-unité GluA1, ainsi que la réduction de conductances potassiques entrainant une hyperexcitabilité neuronale in vitro et in vivo dans la LHb. Ces modifications sont nécessaires pour l’établissement d’états dépressifs émergeant lors de la période de sevrage à la cocaïne. En conclusion, ce travail a contribué à la compréhension de mécanismes de plasticité synaptique ayant lieu au niveau de la LHb et leurs répercussions pour son activité contrôlant ainsi des comportements motivationnels. / The capacity of the brain to anticipate and seek future rewards or alternatively escape aversive events allows individuals to adapt to their environment. A considerable research effort has focused on unraveling the cellular and synaptic mechanisms within the meso-cortico-limbic system underlying motivational processing both in physiological conditions and in pathologies such as addiction and depression. However, only recently we begin to understand the circuit substrates capable to control midbrain monoaminergic nuclei and their contribution to motivated behaviors. The Lateral Habenula (LHb) has emerged in the last decade, as a major player encoding stimuli with motivational value and in controlling monoaminergic systems. The wiring of this epithalamic structure subserves discrete features of motivated behaviors, including preference and avoidance. Recent advances have also demonstrated that aberrant modifications in LHb function trigger negative emotional states in disorders including depression and addiction, highlighting the LHb as an important brain target for therapeutic intervention for these pathological states. In my thesis work I first sought to investigate how modulation of synaptic transmission in the LHb controls neuronal activity, especially focusing on the role of metabotropic glutamate receptors. In a second study, I expanded my work examining how drug experience changes synaptic transmission in a precise habenular circuit that we discovered to be crucial for depressive states during cocaine withdrawal. In an initial data set, we found that, in the LHb, metabotropic glutamate receptor 1 activation drives a PKC-dependent long term depression of excitatory (eLTD) and inhibitory (iLTD) synaptic transmission. Despite the common induction, eLTD and iLTD diverged in their expression mechanism. While eLTD required endocannabinoid-dependent reduction of glutamate release, iLTD expressed postsynaptically through a decrease of β2-containing GABAA receptors function. Further, eLTD and iLTD bidirectionally controlled LHb neuronal output. In a second study, we showed that chronic cocaine exposure leads to a persistent and projection-specific increase of excitatory synaptic transmission onto LHb neurons. This form of synaptic potentiation required membrane insertion of GluA1-containing AMPA receptors and a reduction in potassium channels function ultimately leading to increased LHb neuronal excitability both in vitro and in vivo. These cocaine-driven adaptations within the LHb were instrumental for depressive-like states emerging after drug withdrawal. Altogether this work demonstrates how synaptic plasticity in the LHb affects neuronal output and thereby contributes to behaviors associated with the pathology of motivation.
24

Expressão dos receptores metabotrópicos de glutamato no sistema visual de ratos e pintos após enucleação ocular. / Expression of metabotropic glutamate receptors in the rat and chick visual system after ocular enucleation.

Rhowena Jane Barbosa de Matos 21 November 2007 (has links)
Os receptores glutamatérgicos metabotrópicos (mGluRs) estão envolvidos nos processos de plasticidade, neurodegeneração e neuroproteção. Avaliamos a expressão de mGluRs no sistema visual de ratos e pintos em diferentes tempos após enucleação ocular. Os animais foram avaliados pelo método de imuno-histoquímica, immunoblotting e RT-PCR, para detecção dos receptores mGluR1,2/3,5 e 7. Foi observado aumento da imunorreatividade (IR) de mGluR1, 5 e 7 no colículo superior, porém não foi observada diferença no núcleo geniculado lateral. Houve aumento na expressão protéica para mGluR1, 5 e 7 e aumento da expressão gênica para mGluR1,5 e 7; por outro lado, ocorreu uma diminuição de mGluR3. No TeO, foi observado aumento da IR para mGluR1 e 5 e diminuição para mGluR2/3. As análises de immunoblotting confirmaram o aumento observado de mGluR1 e diminuição de mGluR2/3. Os resultados indicam uma modulação diferencial na expressão gênica e protéica dos mGluRs, sugerindo a participação desses receptores em processos plásticos decorrentes de lesões no sistema visual adulto. / The metabotropic glutamate receptors (mGluRs) are involved in neuronal plasticity and neuroprotection. We analyzed the expression of mGluRs in the visual system of rats and chicks in several periods after ocular enucleation. The localization and expression of mGluR1, 5, 2/3 and 7 receptors were evaluated by standard immunoperoxidase, immunoblotting and real-time PCR protocols. The immunorreativity, protein and gene expression of mGluR1, 5 and 7 receptors in the superior colliculus showed an increase, whereas no changes were seen in the lateral geniculate nucleus. For mGluR3, gene expression was decreased. In the TeO, mGluR1 and 5 increased for all survival periods analyzed. Immunoblotting analyses confirmed the increases for mGluR1 and 5, decreases for mGluR2/3. These results indicate that the expression of mGluRs is regulated by the glutamatergic retinal input, and add data on a possible role of these receptors in neuroplasticity in adult animals.
25

Conception et synthèse de nouveaux agonistes de récepteurs métabotropiques du glutamate / Design and synthesis of metabotropic glutamate receptors agonists

Commare, Bruno 28 November 2014 (has links)
Le glutamate est le principal neurotransmetteur excitateur du système nerveux central. Il est responsable de la majorité des transmissions synaptiques. En revanche, cet acide aminé naturel est aussi impliqué dans de nombreuses neuropathologies notamment en cas de surconcentration au niveau des synapses. Les récepteurs métabotropiques du glutamate, capables de moduler la transmission synaptique, constituent des cibles thérapeutiques prometteuses. Ces récepteurs sont divisés en trois groupes et notre laboratoire s’est focalisé sur ceux du groupe III et particulièrement le sous-type 4 qui présente des caractéristiques intéressantes dans le traitement symptomatique de la douleur et de la maladie de Parkinson. Le manque d’outils pharmacologiques de ce récepteur nous a poussé à synthétiser de nouveaux agonistes orthostériques à partir du composé référence, le LSP4-2022. Cette molécule est issue de nombreuses optimisations chimiques du (S)-PCEP provenant lui d’un screening virtuel. Durant ces trois années de doctorat, nous avons pu peaufiner la relation structure-activité autour du LSP4-2022 en synthétisant des nouveaux analogues fluorés et hétérocycliques. En parallèle, une seconde étude nous a permis d’attribuer la configuration des deux diastéréomères constituants tous les composés testés à ce jour / Glutamate is the major excitatory neurotransmitter in the central nervous system. It is responsible of the majority of synaptic transmissions. In contrast, this natural amino acid is also involved in numerous neuropathologies and particularly in case of glutamate overconcentration in the synapse. Metabotropic glutamate receptors, that can modulate synaptic transmission, thus constitute promising therapeutic targets. These receptors are divided in three groups and our laboratory has been focused in group III and especially subtypes 4 which own interested properties in symptomatic treatment of pain and Parkinson Disease. The lack of pharmacological tools targeting this receptor prompts us to synthesize novel orthosteric agonist from the hit compound LSP4-2022. This molecule was obtained after several chemical optimizations from (S)-PCEP discovered from virtual screening. During my Ph.D., we could refine the structure-activity relationship of LSP4-2022 synthesizing new fluorinated and heterocyclic derivatives. Besides, a second study was carried out to identify the configuration of the two diastereomers which form tested compounds
26

Synthesis of original fluorinated cyclopropylcarboxylates / Synthèse des cyclopropylcarboxylates fluorés originaux

Ivashkin, Pavel 22 November 2013 (has links)
Les composés organofluorés constituent une grande partie de produits pharmaceutiques, ainsi que pesticides, herbicides et matériaux fabriqués actuellement. Développement des méthodes sélectives de la synthèse des composés organofluorés est donc d'intérêt principal pour la chimie. Dans cette thèse, nous décrivons la nouvelle méthode de synthèse des cyclopropanes monofluorés basé sur la cyclisation initiée par la réaction de Michaël (MIRC). Notre méthode permet d'obtenir les cyclopropanes monofluorés polysubstitués à partir de dibromofluorocetate d'éthyle et différents accpteurs de Michaël. Nous avons aussi réalisé la cyclopropanation asymétrique en utilisant le nouveau réactif fluoré chiral à base d'oxazolidinone. Dans la partie finale de cette thèse nous décrivons la synthèse de l'analogue fluoré de L-FAP4, l'agoniste puissant des récepteurs métabotropiques de glutamate groupe II(mGluR II), afin d'augmenter l'activité biologique et la biodisponibilité de ce composé. / Organofluorine compounds constitute a large part of all the drugs, crop protection agents and advanced materials produced nowadays. Therefore, there is a great interest in developing the new methods of synthesis of organofluorine compounds. In this thesis we report a novel method of synthesis of monofluorinated cyclopropanes based on the Michael-initiating ring closure (MIRC) reaction. Our method allows obtaining polysubstituted monofluorinated cyclopropanes from ethyl dibromofluoroacetate and various Michael acceptors. We have also implemented the asymetric version of cyclopropanation using a novel oxazolodinone-derived chiral fluorinated reagent. In the final part of this thesis we report the synthesis of a fluorinated analog of L-FAP4, a potent agonist of group II metabotropic glutamate receptors (mGluR II). Incorporation of a fluorine atom is expected to increase the biological activity and bioavailabiblity of this compound.
27

Modulation of mGlu5 Improves Sensorimotor Gating Deficits in Rats Neonatally Treated With Quinpirole Through Changes in Dopamine D2 Signaling

Brown, Russell W., Varnum, Christopher G., Wills, Liza J., Peeters, Loren D., Gass, Justin T. 01 December 2021 (has links)
This study analyzed whether the positive allosteric modulator of metabotropic glutamate receptor type 5 (mGlu5) 3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl) benzamide (CDPPB) would alleviate deficits in prepulse inhibition (PPI) and affect dopamine (DA) D2 signaling in the dorsal striatum and prefrontal cortex (PFC) in the neonatal quinpirole (NQ) model of schizophrenia (SZ). Male and female Sprague-Dawley rats were neonatally treated with either saline (NS) or quinpirole HCL (1 mg/kg; NQ), a DAD2 receptor agonist, from postnatal days (P) 1–21. Rats were raised to P44 and behaviorally tested on PPI from P44-P48. Before each trial, rats were subcutaneous (sc) administered saline or CDPPB (10 mg/kg or 30 mg/kg). On P50, rats were given a spontaneous locomotor activity test after CDPPB or saline administration. On P51, the dorsal striatum and PFC were evaluated for both arrestin-2 (βA-2) and phospho-AKT protein levels. NQ-treated rats demonstrated a significant deficit in PPI, which was alleviated to control levels by the 30 mg/kg dose of CDPPB. There were no significant effects of CDPPB on locomotor activity. NQ treatment increased βA-2 and decreased phospho-AKT in both the dorsal striatum and PFC, consistent with an increase DAD2 signaling. The 30 mg/kg dose of CDPPB significantly reversed changes in βA-2 in the dorsal striatum and PFC and phospho-AKT in the PFC equivalent to controls. Both doses of CDPPB produced a decrease of phospho-AKT in the PFC compared to controls. This study revealed that a mGlu5 positive allosteric modulator was effective to alleviate PPI deficits and striatal DAD2 signaling in the NQ model of SZ.
28

Beyond AMPA and NMDA: Slow synaptic mGlu/TRPC currents : Implications for dendritic integration

Petersson, Marcus January 2010 (has links)
<p>In order to understand how the brain functions, under normal as well as pathological conditions, it is important to study the mechanisms underlying information integration. Depending on the nature of an input arriving at a synapse, different strategies may be used by the neuron to integrate and respond to the input. Naturally, if a short train of high-frequency synaptic input arrives, it may be beneficial for the neuron to be equipped with a fast mechanism that is highly sensitive to inputs on a short time scale. If, on the contrary, inputs arriving with low frequency are to be processed, it may be necessary for the neuron to possess slow mechanisms of integration. For example, in certain working memory tasks (e. g. delay-match-to-sample), sensory inputs may arrive separated by silent intervals in the range of seconds, and the subject should respond if the current input is identical to the preceeding input. It has been suggested that single neurons, due to intrinsic mechanisms outlasting the duration of input, may be able to perform such calculations. In this work, I have studied a mechanism thought to be particularly important in supporting the integration of low-frequency synaptic inputs. It is mediated by a cascade of events that starts with activation of group I metabotropic glutamate receptors (mGlu1/5), and ends with a membrane depolarization caused by a current that is mediated by canonical transient receptor potential (TRPC) ion channels. This current, denoted I<sub>TRPC</sub>, is the focus of this thesis.</p><p>A specific objective of this thesis is to study the role of I<sub>TRPC</sub> in the integration of synaptic inputs arriving at a low frequency, < 10 Hz. Our hypothesis is that, in contrast to the well-studied, rapidly decaying AMPA and NMDA currents, I<sub>TRPC</sub> is well-suited for supporting temporal summation of such synaptic input. The reason for choosing this range of frequencies is that neurons often communicate with signals (spikes) around 8 Hz, as shown by single-unit recordings in behaving animals. This is true for several regions of the brain, including the entorhinal cortex (EC) which is known to play a key role in producing working memory function and enabling long-term memory formation in the hippocampus.</p><p>Although there is strong evidence suggesting that I<sub>TRPC</sub> is important for neuronal communication, I have not encountered a systematic study of how this current contributes to synaptic integration. Since it is difficult to directly measure the electrical activity in dendritic branches using experimental techniques, I use computational modeling for this purpose. I implemented the components necessary for studying I<sub>TRPC</sub>, including a detailed model of extrasynaptic glutamate concentration, mGlu1/5 dynamics and the TRPC channel itself. I tuned the model to replicate electrophysiological in vitro data from pyramidal neurons of the rodent EC, provided by our experimental collaborator. Since we were interested in the role of I<sub>TRPC</sub> in temporal summation, a specific aim was to study how its decay time constant (τ<sub>decay</sub>) is affected by synaptic stimulus parameters.</p><p>The hypothesis described above is supported by our simulation results, as we show that synaptic inputs arriving at frequencies as low as 3 - 4 Hz can be effectively summed. We also show that τ<sub>decay</sub> increases with increasing stimulus duration and frequency, and that it is linearly dependent on the maximal glutamate concentration. Under some circumstances it was problematic to directly measure τ<sub>decay</sub>, and we then used a pair-pulse paradigm to get an indirect estimate of τ<sub>decay</sub>.</p><p>I am not aware of any computational model work taking into account the synaptically evoked I<sub>TRPC</sub> current, prior to the current study, and believe that it is the first of its kind. We suggest that I<sub>TRPC</sub> is important for slow synaptic integration, not only in the EC, but in several cortical and subcortical regions that contain mGlu1/5 and TRPC subunits, such as the prefrontal cortex. I will argue that this is further supported by studies using pharmacological blockers as well as studies on genetically modified animals.</p> / QC 20101005
29

Le récepteur métabotropique du glutamate de type 4 comme cible thérapeutique pour la maladie de Parkinson / Targeting metabotropic glutamate receptor 4 for the treatment of Parkinson' s disease

Bennouar, Khaled-Ezaheir 26 June 2012 (has links)
La maladie de Parkinson (MP) est une maladie neurodégénérative chronique qui apparait en moyenne à partir 55 ans. Sa cause reste inconnue mais son apparition et son développement sont corrélés avec la perte progressive des neurones dopaminergique de la substance noire qui innervent les ganglions de la base (GB). Jusqu'à ce jour le traitement le plus efficace est basé sur la compensation du déficit en dopamine (DA) par l'administration de son précurseur, la L-DOPA, qui est métabolisé en DA. Ce traitement améliore les symptômes moteurs de la maladie et donc la qualité de vie des patients. Néanmoins, après une certaine période des effets secondaires invalidants apparaissent, en particulier des fluctuations motrices et des mouvements anormaux involontaires appelés dyskinésies. De plus, ce traitement n'apporte pas de réponse à la progression de la dégénérescence et donc de la maladie. C'est pour ces raisons que la communauté scientifique est à la recherche d'une thérapie pharmacologique alternative à la L-DOPA, ou du moins visant à minimiser ses effets indésirables. Dans ce contexte, les récepteurs métabotropiques du glutamate, en particulier mGluR4, semblent constituer une cible privilégiée. En effet, mGluR4 est situé à des synapses des GB supposées hyperactives dans la MP, et son activation par des moyens pharmacologiques pourrait donc rétablir une activité normale grâce à son action inhibitrice sur la libération de neurotransmetteur. Nos résultats démontrent le bien-fondé de cette hypothèse sur le plan fonctionnel, en utilisant un nouvel agoniste allostérique spécifique de mGluR4, Lu AF21934. / Parkinson's disease (PD) is a progressive neurodegenerative disorder that appears around 55 years of age. The causes of PD remain unknown but its appearance and progression are correlated with the progressive loss of dopaminergic neurons of substantia nigra pars compacta innervating the basal ganglia (BG). Up to date, the most efficient treatment is based on restoring a normal level of dopamine (DA) in the brain by the administration of L-DOPA, a DA precursor that is metabolized to DA. However, at long term, L-DOPA treatment induces some side-effects, in particular the highly disabling L-DOPA-induced dyskinesia (LID). For this reason, the scientific community is searching for a pharmacological treatment alternative to L-DOPA and/or minimizing LID. In this context, metabotropic glutamate receptors, in particular mGluR4, are targets of interest. mGlu4 are localized at presynaptic terminals within BG circuitry that become hyperactive in PD. For this reason, mGluR4 has been considered a key strategic target for non-dopaminergic pharmacological treatments aimed at modulating these synapses, due to its ability to reduce neurotransmitter release. Herein we provide physiological and functional support to this hypothesis using Lu AF21934, a novel selective and brain-penetrant mGluR4 positive allosteric modulator (PAM). By in vitro electrophysiological recordings we demonstrate that Lu AF21934 inhibits corticostriatal synaptic transmission. In rats rendered parkinsonian, Lu AF21934 combined with sub-threshold doses of L-DOPA acted synergistically in alleviating akinesia in a dose-dependent manner and, notably, also reduced the incidence of LID.
30

Modulation of N-methyl-D-aspartate receptors by Gαs- and Gαi/o-coupled receptors

Trepanier, Catherine Helene 07 January 2013 (has links)
The induction of synaptic plasticity at CA1 synapses requires NMDAR activation. Modulation of NMDAR function by various GPCRs can shift the thresholds for LTP and LTD induction and contribute to metaplasticity. Here we showed that the activity of GluN2A- and GluN2B-containing NMDARs is differentially regulated by Gαi/o-coupled, Gαq- and Gαs-coupled receptors. Furthermore, enhancing the relative function of GluN2A-to-GluNB NMDAR activity by GPCRs can alter the balance of LTP and LTD induction and contribute to metaplasticity. In CA1 neurons, activation of the Gαs-coupled D1/D5R selectively recruited Fyn kinase and enhanced GluN2B-mediated NMDAR currents. Biochemical experiments confirmed that D1/D5R stimulation activates Fyn kinase and enhances the tyrosine phosphorylation of GluN2B subunits. In contrast, activation of the Gαq-coupled PAC1R selectively recruited Src kinase to enhance the function of GluN2A-containing NMDARs. Enhancing the functional ratio of GluN2A-to-GluN2B subunits by PAC1R activation lowered the threshold for LTP induction whereas enhancing the functional ratio of GluN2B-to-GluN2A subunits by D1/D5R activation increased the threshold for LTP induction. Unexpectedly, activation of the Gαi/o-coupled mGluR2/3 enhanced NMDAR-mediated function via a previously unidentified mechanism. Inhibition of the cAMP-PKA pathway via mGluR2/3 activation resulted in activation of Src via decreased phosphorylation of its C-terminal Tyr527 by Csk. Stimulation of mGluR2/3 selectively potentiated the function of GluN2A-containing NMDARs but whether it shifted the modification threshold θm to the left requires further investigation.

Page generated in 0.0566 seconds